Financials Siemens Healthineers AG

Equities

Real-time Estimate Tradegate Other stock markets 12:40:14 19/09/2024 BST			5-day change	1st Jan Change
50.17 ^EUR	+0.88%		+0.36%	-4.60%

09-11	SIEMENS HEALTHINEERS : Gets a Buy rating from Berenberg	ZD
08-30	Siemens Healthineers wants to expand nuclear diagnostics with acquisition	RE

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	14,518	14,460	17,997	21,714	21,680	22,462	23,921	25,455
Change	-	-0.4%	24.46%	20.65%	-0.16%	3.61%	6.5%	6.41%
EBITDA ¹	2,920	2,796	3,612	4,269	3,692	4,470	5,210	5,747
Change	-	-4.25%	29.18%	18.19%	-13.52%	21.06%	16.57%	10.3%
EBIT ¹	2,300	2,230	3,142	3,655	3,081	3,519	4,135	4,614
Change	-	-3.04%	40.9%	16.33%	-15.7%	14.22%	17.5%	11.59%
Interest Paid ¹	-123	-27	-170	-127	-207	-272.9	-250.2	-231.4
Earnings before Tax (EBT) ¹	2,193	1,954	2,404	2,800	1,928	2,544	3,362	3,929
Change	-	-10.9%	23.03%	16.47%	-31.14%	31.97%	32.15%	16.85%
Net income ¹	1,567	1,411	1,727	2,038	1,509	1,977	2,502	2,909
Change	-	-9.96%	22.4%	18.01%	-25.96%	30.99%	26.59%	16.23%
Announcement Date	04/11/19	02/11/20	04/11/21	09/11/22	08/11/23	-	-	-

¹EUR in Million

Estimates

Fiscal Period: September	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3
Net sales ¹	4,142	3,587	3,685	3,312	3,876	3,868	3,965	5,000	5,164	5,068	5,460	5,186	6,000	5,077	5,346	5,201	6,056	5,176	5,435	5,423	6,357	5,342	5,695	5,717
Change	-	-13.4%	2.73%	-10.12%	17.03%	-0.21%	2.51%	26.1%	3.28%	-1.86%	7.73%	-5.02%	15.7%	-15.38%	5.3%	-2.71%	16.44%	-14.53%	5%	-0.22%	17.23%	-15.98%	6.62%	0.38%
EBITDA ¹	-	-	-	-	-	-	-	-	-	-	1,116	938	1,211	-	-	-	-	885	917	974	1,430	1,038	1,159	1,194
Change	-	-	-	-	-	-	-	-	-	-	-	-15.95%	29.1%	-100%	-	-	-	-	3.62%	6.22%	46.77%	-27.41%	11.65%	3.07%
EBIT ¹	732	484	659	461	626	738	666	945	793	898	980	765	1,011	647	681	740	1,013	742	822	825	1,104	-	-	-
Change	-	-33.88%	36.16%	-30.05%	35.79%	17.89%	-9.76%	41.89%	-16.08%	13.24%	9.13%	-21.94%	32.16%	-36%	5.26%	8.66%	36.89%	-26.75%	10.78%	0.36%	33.78%	-100%	-	-
Charge d'intérêts	-15	-21	-18	-13	-	-	-14	-86	-27	-	-13	-69	-21	-	-47	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	419	582	403	550	606	617	586	-	661	-	-	-	-	-	-	-	543	541	595	856	594.9	713.9	746.3
Change	-	-	38.9%	-30.76%	36.48%	10.18%	1.82%	-5.02%	-100%	-	-100%	-	-	-	-	-	-	-	-0.37%	9.98%	43.87%	-30.5%	19.99%	4.55%
Net income ¹	502	301	411	270	428	432	443	390	462	466	579	363	630	421	105	451	537	431	426	469	696.1	-	-	-
Change	-	-40.04%	36.54%	-34.31%	58.52%	0.93%	2.55%	-11.96%	18.46%	0.87%	24.25%	-37.31%	73.55%	-33.17%	-75.06%	329.52%	19.07%	-19.74%	-1.16%	10.09%	48.42%	-100%	-	-
Announcement Date	04/11/19	03/02/20	05/05/20	02/08/20	02/11/20	26/01/21	03/05/21	30/07/21	04/11/21	03/02/22	04/05/22	03/08/22	09/11/22	02/02/23	16/05/23	02/08/23	08/11/23	01/02/24	07/05/24	31/07/24	-	-	-	-

¹EUR in Million

Estimates

¹EUR in Million

Estimates

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	3,174	4,891	11,068	12,049	15,018	12,055	10,742	9,469
Change	-	54.1%	126.29%	8.86%	24.64%	-19.73%	-10.89%	-11.85%
Announcement Date	04/11/19	02/11/20	04/11/21	09/11/22	08/11/23	-	-	-

¹EUR in Million

Estimates

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	579	557	674	852	838	929	989.9	1,036
Change	-	-3.8%	21.01%	26.41%	-1.64%	10.86%	6.55%	4.71%
Free Cash Flow (FCF) ¹	1,038	1,371	2,259	1,652	1,281	2,238	2,964	3,180
Change	-	32.08%	64.77%	-26.87%	-22.46%	74.75%	32.43%	7.28%
Announcement Date	04/11/19	02/11/20	04/11/21	09/11/22	08/11/23	-	-	-

¹EUR in Million

Estimates

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	20.11%	19.34%	20.07%	19.66%	17.03%	19.9%	21.78%	22.58%
EBIT Margin (%)	15.84%	15.42%	17.46%	16.83%	14.21%	15.67%	17.28%	18.13%
EBT Margin (%)	15.11%	13.51%	13.36%	12.89%	8.89%	11.33%	14.06%	15.44%
Net margin (%)	10.79%	9.76%	9.6%	9.39%	6.96%	8.8%	10.46%	11.43%
FCF margin (%)	7.15%	9.48%	12.55%	7.61%	5.91%	9.97%	12.39%	12.49%
FCF / Net Income (%)	66.24%	97.17%	130.8%	81.06%	84.89%	113.25%	118.47%	109.34%
Profitability
ROA	7.61%	6.07%	6.64%	5.65%	4.72%	4.59%	5.44%	6%
ROE	17.01%	14.3%	15.5%	14.26%	12.8%	12.7%	14.08%	14.91%
Financial Health
Leverage (Debt/EBITDA)	1.09x	1.75x	3.06x	2.82x	4.07x	2.7x	2.06x	1.65x
Debt / Free cash flow	3.06x	3.57x	4.9x	7.29x	11.72x	5.39x	3.62x	2.98x
Capital Intensity
CAPEX / Current Assets (%)	3.99%	3.85%	3.75%	3.92%	3.87%	4.14%	4.14%	4.07%
CAPEX / EBITDA (%)	19.83%	19.92%	18.66%	19.96%	22.7%	20.78%	19%	18.03%
CAPEX / FCF (%)	55.78%	40.63%	29.84%	51.57%	65.42%	41.5%	33.39%	32.59%
Items per share
Cash flow per share ¹	1.62	1.913	2.666	2.22	1.882	2.944	3.699	3.808
Change	-	18.09%	39.38%	-16.73%	-15.25%	56.43%	25.66%	2.95%
Dividend per Share ¹	0.8	0.8	0.85	0.85	0.95	1.013	1.185	1.326
Change	-	0%	6.25%	0%	11.76%	6.64%	16.95%	11.89%
Book Value Per Share ¹	9.788	12.49	14.84	17.67	16.2	17	18.22	19.61
Change	-	27.6%	18.82%	19.05%	-8.27%	4.89%	7.17%	7.68%
EPS ¹	1.57	1.4	1.57	1.81	1.34	1.79	2.231	2.594
Change	-	-10.83%	12.14%	15.29%	-25.97%	33.6%	24.61%	16.27%
Nbr of stocks (in thousands)	999,223	1,072,798	1,122,335	1,118,252	1,119,394	1,115,788	1,115,788	1,115,788
Announcement Date	04/11/19	02/11/20	04/11/21	09/11/22	08/11/23	-	-	-